Indegene Past Earnings Performance
Past criteria checks 5/6
Indegene has been growing earnings at an average annual rate of 25.3%, while the Life Sciences industry saw earnings growing at 20.2% annually. Revenues have been growing at an average rate of 9.7% per year. Indegene's return on equity is 15.8%, and it has net margins of 13.8%.
Key information
25.3%
Earnings growth rate
23.4%
EPS growth rate
| Life Sciences Industry Growth | 11.2% |
| Revenue growth rate | 9.7% |
| Return on equity | 15.8% |
| Net Margin | 13.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Indegene makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 27,097 | 3,730 | 17,322 | 0 |
| 30 Jun 24 | 26,586 | 3,560 | 16,912 | 0 |
| 31 Mar 24 | 25,896 | 3,367 | 16,560 | 0 |
| 31 Dec 23 | 25,489 | 2,907 | 16,452 | 0 |
| 30 Jun 23 | 23,927 | 2,487 | 15,593 | 0 |
| 31 Mar 23 | 23,061 | 2,661 | 14,688 | 0 |
| 31 Mar 22 | 16,646 | 1,648 | 10,222 | 0 |
| 31 Mar 21 | 9,806 | 1,857 | 5,403 | 0 |
| 31 Mar 20 | 6,436 | 558 | 3,738 | 0 |
Quality Earnings: 544172 has high quality earnings.
Growing Profit Margin: 544172's current net profit margins (13.8%) are higher than last year (10.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 544172's earnings have grown significantly by 25.3% per year over the past 5 years.
Accelerating Growth: 544172's earnings growth over the past year (38.3%) exceeds its 5-year average (25.3% per year).
Earnings vs Industry: 544172 earnings growth over the past year (38.3%) exceeded the Life Sciences industry 13.3%.
Return on Equity
High ROE: 544172's Return on Equity (15.8%) is considered low.